Active Not RecruitingNCT03352765
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
PHASE1 · 28 planned enrolment
- Countries listed
- 1
- Registry update
- December 4, 2025
